IFM Therapeutics
PrivateLast Round
VC Round
Dec 2, 2019
Total Funding Raised
$58M
Company Overview
IFM Therapeutics is a biopharmaceutical company that develops small molecule medicines aimed at enhancing immunotherapy by precisely targeting the innate immune system to address complex issues in treating inflammatory and autoimmune disorders as well as cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IFM Therapeutics Comparables
Compare IFM Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ventus Therapeutics | 89% | |
| Olatec Therapeutics | 86% | |
| Inflammasome Therapeutics | 81% | |
IFM Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 2, 2019 | ||||
| Series A | Jul 19, 2018 | ||||
| M&A | Aug 3, 2017 | ||||
| Series A | Jun 21, 2016 | ||||
| Seed | Oct 1, 2015 |
Key People
Founding team and executive leadership
IFM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | VC Round |
| Abingworth | Series A, VC Round |
| Atlas Venture | Series A, VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 19, 2018
$31M round with participation from Abingworth and Atlas Venture.
- Jun 21, 2016
$27M round led by Abingworth and Atlas Venture.
IFM Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IFM Therapeutics's valuation, stock price, and market status.